Impact Of Timing Of Drainage Of Massive Ascites On Operative And Post-Operative Course In Living-Donor Liver Transplant Recipients. A Prospective Randomized Controlled Trial.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02867293

Acronym

AscitesLDLT

Enrollment

Registered

2016-08-15

Start date

2013-01-31

Completion date

2016-01-31

Last updated

2016-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Massive Ascites

Brief summary

Massive ascites is usually controlled over several weeks pre-operatively in liver transplant recipients with the risk of encephalopathy and peritonitis. We hypothesized that intra-operative drainage of ascites will be safe and avoids the inherent risks of pre-operative drainage.

Interventions

PROCEDUREultrasound guided ascitic fluid drainage

PROCEDUREoperative drainage of ascites through small skin incision after induction of anesthesia

DEVICEultrasound

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

20 Years to 60 Years

Healthy volunteers

Inclusion criteria

* liver transplant candidates with tense acsites

Exclusion criteria

* severe coagulpathy (INR more than 2 or platlet count less than 50) MELD more than 20

Design outcomes

Primary

Measure	Time frame
graft survival	one year

Secondary

Measure	Time frame
patient survival	one year

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026